Speech Therapy x2 clinics. NDIS co# sale. NSW

About the Business

Regional Paediatric Speech PathPractice| FY26 Revenue $2.5M

For over a decade,this respected paediatricbusiness has grown into the largest private practice of its kind in the area and now operates from a couple ofclinic locations supported by a team of professionals, including a dozen or soFTE speech pathologists.

The business is NDIS Early Childhood Intervention registered, fully accredited and recognised through multiple awards over the last few years. FY26 turnover reached approx$2.5M. What this means for the community they support is that the parents can feel confident that theyhave robust systems in place to support:
- Safe, child-focused therapy
- Qualified and well-supported clinicians
- Consistent, high-quality clinical documentation
- Strong privacy and information management
- Clear processes for feedback, complaints and continuous improvement
- Ongoing review of the quality of the services we provide


The business is not dependent on the owner for day-to-day operations. A Clinical Director, fractional CFO and Marketing Director support management, allowing the owner to spend limited time in the clinics while maintaining performance.

Highlights
- Long-established workforce
- Average retention of 3 to 3.5 years and several team members exceeding 8 years
- Strong recruitment pipeline with two new graduates commencing in 2027
- Above-award remuneration and substantial professional development investment
- No current workers compensation claims
- Existing school, early learning and family support program relationships
- Government-funded universal support contract valued at $35,000
- Curated referral networks and strong reputation
- No current waiting list, providing immediate service capacity


The vendor also owns another business servicing allied health professionals. Growing commitments in that venture, together with a desire to pursuenational opportunities, have created a genuine reason for sale.

Offered as a 100% share sale, this acquisitionwould be ideal for larger private providers, NFP organisations or strategic acquirers seeking an established workforce, scalable platform and leading market position in paediatric speech pathology.

Price: $495,000 ONO.Enquire today to receive a detailed IM and further financial information.Brokers - Sally Stuart and Luisa Heenan ([email protected] [email protected])
REF: NSW12318
Corporate Licence: 1417054
Ref: NSW12318
Timestamp: 20261109043003